PRECISEU Matchmaking Platform

20 Oct 2025 – 30 Apr 2026 | Barcelona, Spain

Register
Register
Register

Business OpportunityUpdated on 5 June 2026

What if patients could maintain healthier behaviors between visits — without increasing clinicians’ workload?

CTO at Bloomi data for life

Barcelona, Spain

About

BLOOMI is a digital longitudinal monitoring platform designed to improve therapeutic adherence and patient support in chronic and oncology care. The platform is already operating in real clinical environments through ongoing studies and collaborations with hospitals and healthcare teams.

Through the BLOOMI app, patients generate longitudinal behavioral, contextual and clinical data in real-world conditions. These data are combined with behavioral science methodologies to better understand therapeutic trajectories, personalize content and interactions, and improve long-term adherence outside traditional episodic care models.

For healthcare providers, BLOOMI is being evaluated as a tool to support earlier identification of therapeutic deviation, improve continuity of care between visits, provide structured insights for patient follow-up and help healthcare teams make more efficient use of clinical resources.

Over the next two years, this infrastructure will support the development of BLOOMI-MODEL, an adaptive inference system designed to develop and validate an adaptive inference system capable of identifying early patterns of functional destabilization and dynamically adapt patient support within routine clinical workflows.

Stage

  • TRL 6

Topic

  • Endocrine/nutritional/metabolic diseases
  • Pregnancy, childbirth and the puerperium

Sector

  • Health data
  • AI
  • Oncology

Type

  • Co-development
  • Clinical validation

Similar opportunities

  • Business Opportunity

    Digital Biomarkers Platform for Respiratory Health

    • AI
    • TRL 6
    • Oncology
    • Physiology
    • Respiratory
    • Health data
    • Diagnostics
    • Rare diseases
    • Rare diseases
    • Cardiovascular
    • Co-development
    • Consortium partners
    • Research collaboration

    Simone Melchionna

    Founder at Medlea

    Rome, Italy

  • Business Opportunity

    AI-based clinical decision support for early detection and validation in women’s health

    • TRL 7
    • Health data
    • Diagnostics
    • Clinical validation
    • Consortium partners
    • Genitourinary system
    • Pregnancy, childbirth and the puerperium

    Nemira Zilinskaite

    CEO & co-founder at Muuza

    Vilnius, Lithuania

  • Business Opportunity

    vitalera: Making Hospital-at-Home a Reality with AI

    • AI
    • TRL 8
    • Oncology
    • Physiology
    • Pediatrics
    • Licensing
    • Respiratory
    • Health data
    • Rare diseases
    • Rare diseases
    • Bioinformatics
    • Cardiovascular
    • Co-development
    • Digestive system
    • Consortium partners
    • Regenerative medicine
    • Research collaboration
    • External causes of morbidity, mortality
    • Injury, poisoning, other external causes
    • Pregnancy, childbirth and the puerperium
    • Musculoskeletal system, connective tissue
    • Other symptoms, deviant clinical findings
    • Diseases of the blood and immune disorders
    • Diseases of the nervous system / neurology
    • Mental and behavioural disorders / psychiatry /psychology

    Nuria Pastor

    General Manager at vitalera

    Barcelona, Spain